Grants per year
Personal profile
Research Interests
General surgical pathology, Pulmonary pathology
Certifications and Licenses
| Anatomic Pathology | |
| Anatomic Pathology & Clinical Pathology |
Training Experience
| 1990 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Gandhi Medical College
… → 1982
Research interests keywords
- Pathology
Fingerprint
Dive into the research topics where Anjana V Yeldandi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Core A: Administration
Sznajder, J. I. (PD/PI), Kwasny, M. J. (Co-PD/PI), Rademaker, A. W. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
4/1/09 → 4/30/15
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. (PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. (PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I. (PD/PI), Budinger, G. S. (Co-PD/PI), Chandel, N. (Co-PD/PI), Glucksberg, M. R. (Co-PD/PI), Goldman, R. (Co-PD/PI), Kamp, D. W. (Co-PD/PI), Ridge, K. M. (Co-PD/PI), Sporn, P. H. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I. (PD/PI), Budinger, G. S. (Co-PD/PI), Chandel, N. (Co-PD/PI), Glucksberg, M. R. (Co-PD/PI), Goldman, R. (Co-PD/PI), Kamp, D. W. (Co-PD/PI), Ridge, K. M. (Co-PD/PI), Sporn, P. H. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
A Gain-of-Function Mutation in Mechanistic Target of Rapamycin Results in a Tuberous Sclerosis Complex-Like Manifestation of Parenchymal Lung Disease
Bolig, T. C., Yeldandi, A. V., Dematte, J. E. & Esposito, A., Apr 2025, In: CHEST. 167, 4, p. e109-e112Research output: Contribution to journal › Article › peer-review
-
Long-Term Multifocal Pulmonary Fibrosis Associated with Y-90 Embolization: A Case Report and Literature Review
Kruse, E., Kim, S. S., Bemiss, B., Parekh, N., Yeldandi, A. & Amgad, M., 2025, (Accepted/In press) In: International Journal of Surgical Pathology.Research output: Contribution to journal › Article › peer-review
-
Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer
Chandrasekhar, A., Yang, H. C., Demir, T., Yeldandi, A., Kurihara, C., Tomic, R., Gao, R., Goldman, J. W., Nadig, S., Chae, Y. K. & Bharat, A., Jan 2025, In: American Journal of Transplantation. 25, 1, p. 209-214 6 p.Research output: Contribution to journal › Article › peer-review
-
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia
The NU SCRIPT Study Investigators, 2024, (Accepted/In press) In: Nature Immunology. 25, 9, p. 1607-1622 16 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma
Wu, E., Reznicek, J., Yeldandi, A. V., Patel, J. D. & Odell, D. D., Jun 2024, In: Clinical Lung Cancer. 25, 4, p. 376-379 4 p.Research output: Contribution to journal › Article › peer-review
Datasets
-
Suppl_Fig._2 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Keijdener, D. L. D. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375524, https://sage.figshare.com/articles/figure/Suppl_Fig_2_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375524
Dataset
-
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4611566, https://sage.figshare.com/collections/The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/4611566
Dataset
-
Suppl_Fig._3 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Sharma, N. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375530, https://sage.figshare.com/articles/figure/Suppl_Fig_3_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375530
Dataset
-
Suppl_Fig._1 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Faivre, J. C. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375521, https://sage.figshare.com/articles/figure/Suppl_Fig_1_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375521
Dataset